Source comparison
MOTS-c vs GLP-1 Agonists, Mitochondrial Peptides, and Exercise Mimetics
MOTS-c AMPK activation, mitochondrial biogenesis +30–40% running time to exhaustion (rodents); +22m 6MWT (older adults) Subcutaneous injection Strongest mechanistic rationale for endurance among mitochondrial peptides; human data limited to elderly populations
This comparison does not assign a generated winner or score.
- MOTS-c
- AMPK activation, mitochondrial biogenesis
- +30–40% running time to exhaustion (rodents); +22m 6MWT (older adults)
- Subcutaneous injection
- Strongest mechanistic rationale for endurance among mitochondrial peptides; human data limited to elderly populations
- Humanin
- Mitochondrial protection, anti-apoptotic
- Minimal direct endurance effects; protective against exercise-induced oxidative stress
- Primarily cytoprotective. Not performance-focused
- SS-31 (Elamipretide)
- Cardiolipin stabilization, mitochondrial membrane integrity
- Improved cardiac output in heart failure models; no endurance trials in healthy subjects
- IV or subcutaneous
- Cardiac-specific benefits; not validated for skeletal muscle endurance
- GLP-1 agonists (semaglutide, tirzepatide)
- Appetite suppression, insulin sensitization
- Indirect via weight loss; no AMPK activation or mitochondrial biogenesis
- Fat loss improves relative power output but doesn't enhance absolute aerobic capacity
- AICAR (exercise mimetic)
- Direct AMPK activation
- +44% running endurance (rodents); banned by WADA
- Injection
- Mechanistically similar to MOTS-c but triggers far broader metabolic disruption
- The comparison clarifies MOTS-c's niche: it sits between protective mitochondrial peptides (Humanin, SS-31) that don't directly boost performance and banned exercise mimetics (AICAR) that activate AMPK but carry significant metabolic side effects. MOTS-c activates the same beneficial pathway. AMPK-driven mitochondrial biogenesis. Without the off-target metabolic consequences that led WADA to ban AICAR.
- Our team has seen researchers combine MOTS-c with other mitochondrial-supporting compounds. The Energy, Mitochondria & Fatigue Elimination Bundle reflects this stacking approach. Though research protocols vary widely and synergistic effects remain unvalidated in controlled trials.